AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS

Similar documents
Borders. Patient Group Direction (PGD) Development Policy For NHS Borders

PATIENT GROUP DIRECTION PROCEDURE

Expiry Date: July 2009 Template Version: Page 1 of 7

Expiry Date: September 2009 Template Version: Page 1 of 7

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the

GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

GG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml

Patient Group Directions (PGDs)

PATIENT GROUP DIRECTION. Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif )

Document Details. Patient Group Direction

GG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Document Details. Patient Group Direction

GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME

NANDTB-F012 Rev 0 Audit Checklist

HEPATITIS A + TYPHOID VACCINE

Clinical Condition Indication:

GUIDANCE DOCUMENTS CONTAINING THE COMMON PROVISIONS ON THE CONDUCT OF GCP INSPECTIONS BY COMPETENT AUTHORITIES OF THE DIFFERENT MEMBER STATES

This document expires on Patient Group Direction No. VI 7

Case scenarios: Patient Group Directions

GG&C PGD ref no: 2018/1589 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Trust Policy 218 Ionising Radiation Safety Policy

Recall Guidelines. for Chinese Medicine Products

Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business

NHS public health functions agreement Service specification No.32 Human papillomavirus immunisation programme for men who have sex with men

Darwin Marine Supply Base HSEQ Quality Management Plan

Policy for the safe use of oral methotrexate

SAFE HANDLING OF VACCINES

This document expires on Patient Group Direction No. VI 5

This document expires on Patient Group Direction No. VI 11

SAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein

Research Licence Renewal Inspection Report

ADMINISTRATION OF INSULIN

CARIBX (UK) LIMITED. Environmental, Health and Safety Management System. Revision: 00 APRIL 2011

This document expires on Patient Group Direction Number VI 19

Care Homes - Homely Remedies Protocol

Controlled Drugs Accountable Officers Network Scotland Executive Group. Gabapentin and Pregabalin - Frequently Asked Questions

Practice Direction Refill History Recording System

Clinician Responsible for Training and Review: Emergency Department Consultant

Patient Group Directions Policy

FOR CHILDREN ATTENDING FOR EXODONTIA UNDER GENERAL ANAESTHETIC

Clinician Responsible for Training and Review: Emergency Department Consultant

BMA INFORMATION BULLETIN No. 23. International Safety Management (ISM) Code

Policy and process for development and management of PGDs for general practice that require SCCG authorisation

Testing Railway Safety Critical Workers for Drugs and Alcohol

School Hearing Screening Policy

Quality, Safety and Sourcing in Unlicensed Medicines

NRT Voucher redemption scheme service specification

Developed By Name Signature Date

Clinical Condition Indication:

POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE. September 2011

Standard Operating Procedure. Selection of studies performed in compliance with Good Laboratory Practice for audit purposes

PATIENT GROUP DIRECTIONS POLICY

National Cancer Peer Review Programme. Radiotherapy Service Evidence Guide

Executive Summary for Executive Licensing Panel 20 May Dr Kamal Ahuja. Follow-up inspection 14 April 2010

making a referral for breast imaging Standard Operating Procedure

North of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines

Feidhmeannacht na Seirbhíse Sláinte

SAMPLE. This direction was authorised on 4/5/2007. The direction will be reviewed by 4/5/2009

CALDERDALE PRIMARY CARE TRUST

TERMS AND CONDITIONS NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes

Care homes - Homely remedies

GEX Recommended Procedure Eff. Date: 07/27/07 Rev.: C Pg. 1 of 10

Guideline for the Rational Use of Controlled Drugs

DE-DESIGNATION OF YELLOW FEVER VACCINATION CENTRES

Approval of Dosimetry Services in Ireland Guidelines for Applicants

Care and Social Services Inspectorate Wales. Care Standards Act Inspection Report. ategi Shared Lives Scheme. Cardiff

History Note: Authority G.S ; ; ; Eff. May 1, 1997; Amended Eff. January 1, 2015; March 1, 2013.

Guidance for Pharmacists on Extemporaneous Dispensing

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian

SAMPLE. PGD reviewed by: Dr Tim Patterson, Chris Faldon, John Maloney, Adrian Mackenzie

Re: Handling of gabapentin and pregabalin as Schedule 3 Controlled Drugs in health and justice commissioned services

Enhanced service specification Childhood seasonal influenza vaccination programme NHS England gateway reference: 01641

Administration of Hepatitis A and B Vaccine

Draft Guidance for Pharmacists on Extemporaneous Dispensing. Version 1

Clinical Condition Indication:

Approval for research carried out on human extracted teeth from Birmingham School of Dentistry Tooth Bank under ethical approval no: 14/EM/2811

An overview of Patient Group Directions (PGDs)

STANDARD FOR PORCINE SEMEN QUALITY IN AI CENTRES

Standard Operating Procedure CPFT/SOP003 Serious Breach of Protocol or GCP in CTIMPs

NATIONAL DENTAL INSPECTION PROGRAMME

Guidance on Bulk Prescribing for Care Home Residents

PATIENT GROUP DIRECTION

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

STANDARD OPERATING PROCEDURE SOP 720 RISK ASSESSMENT OF TRIALS SPONSORED. BY THE NNUH and UEA

Evidence-Based Clinical Practice Guideline. Treatment & Management of Ocular Disease

CHAPTER 4 POST-MARKETING SURVEILLANCE OF DRUGS

INITIAL PRACTICE PERIOD FORMS

REGIONAL PHARMACY SPECIALIST SMOKING CESSATION SERVICE FEBRUARY A Pharmacist s Guide

Testing Railway Safety Critical Workers for Drugs and Alcohol

PRESCRIBING SUPPORT TEAM AUDIT: ACE Inhibitors in the treatment of stable angina (October 2007) PRESCRIBING SUPPORT TECHNICIAN:

Monday, 22 January 2018 HFEA, 10 Spring Gardens, London SW1A 2BU

Community Pharmacy Enhanced Service. Just In Case 4 Core Drugs supply. Stock Holding of Palliative Care Medicines

Guidance for the Network Review of Chemotherapy Errors

Transcription:

AUDIT TOOL FOR DISPENSING SERVICES COMPILED BY: Lynn Morrison ISSUE 1 CHECKED BY: Colette Byrne NUMBER: ISSUE DATE: 01.12.07 SUPERSEDES: NEW REVIEW DATE: 01.12.09 AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS Please record details in table below. The completed Audit Tool should be returned by email to PGD@ggc.scot.nhs.uk or by post to PGD Administration, Pharmacy and Prescribing Support Unit, Queens Park House, Victoria Infirmary, Langside Drive, Glasgow Telephone 0141 201 5215 Please retain a copy for your files. Date(s) of Audit Auditor(s) Job Title(s) COMMENTS

SCOPE Examination of Patient Group Directions AIMS OF A PATIENT GROUP DIRECTION SERVICE To provide a safe and efficient service which satisfies patient requirements. To provide patients with the correct medicinal products in accordance with patient group directions. To ensure all products held in stock are stored under the correct conditions required to assure quality for patients. AIMS OF THE AUDIT a) To specify standards, in the form of acceptance criteria, as agreed with local and national policy and guidelines. b) To provide a means of monitoring performance against these standards. c) To identify and initiate action to rectify deficiencies surrounding the administration of medicines under PGDs. d) To aid in the continuous improvement of the Service. e) To report results of audits to Clinical Governance Committee and PGD Sub Group. ACCEPTANCE CRITERIA a) As listed in this audit tool. b) The criteria encompass critical components of the service, i.e., factors which will impact upon the quality of the medicinal product. c) The agreed criteria will be reviewed and revised by the RQAS on an annual basis and/or whenever considered necessary, e.g., as a result of legislative or local/national policy changes. METHODS OF MONITORING a) Inspecting records for evidence of completion and within limits or note of action taken. b) Examining by inspection of the procedures and documentation. c) Observing tasks being undertaken. d) Discussing with relevant personnel.

SCORING SYSTEM Y = Complete Compliance with acceptance criteria N = Does NOT Comply N/A = Not Applicable For each section within the audit schedule, deficiencies are categorised based on the level of non-compliance with the acceptance criteria and the risk to patient safety / product quality. Critical = high risk requiring an immediate corrective action plan to rectify non-compliance(s) Major = medium risk requiring a short-medium term corrective action plan to rectify non-compliance(s) Other = corrective action plan required to rectify non-compliance(s) Satisfactory = complies with standards REFERENCES The following guidelines and local in-house documents may be referred to in the course of the audit: National Guidelines 1. Patient Group Directions Best Practice Statement 2006 Local In-House Documentation (which may include): 1. Departmental Policy Manual 2. Patient Group Directions 3. Standard Operating Procedures (SOP) 4. Patient records / notes Separate audits to be carried out for each PGD in the department.

Section No: 1 Management Category: Critical / Major / Other / Satisfactory No Acceptance Criteria Audit Result Comments 1.1 General statements 1.1.1 The Patient Group Direction (PGD) under inspection is still clinically relevant 1.1.2 The PGD reflects content of current Summary of Product Characteristics (SPC) 1.1.3 The PGD is within its expiry date 1.1.4 The PGD has not been suspended 1.1.5 Practitioners operating under PGD are as stated in the PGD 1.1.6 There is evidence of approval of the PGD for use within the particular department 1.2 Review of PGDs 1.2.1 There is a system to ensure that changes to PGDs are controlled 1.2.2 There is evidence that any changes required (e.g. alterations in product licence) have been put in place via the PGD group.

Section No: 2 Training Category: Critical / Major / Other / Satisfactory No Acceptance Criteria Audit Result Comments 2.1 Training for working under the direction of a PGD 2.1.1 Training programmes have been developed and implemented 2.1.2 There is evidence that all practitioners utilising the PGD have been appropriately trained training records 2.1.3 Competency should be re-assessed at regular intervals a re-assessment programme should be available 2.1.4 There is evidence of re-assessment and continuing competency 2.2 Additional training requirements e.g. IV administration, cannulation, vaccine administration 2.2.1 Any additional training requirements for operating under the PGD have been met through appropriate training programmes 2.2.2 Competency requirements have been assessed and operator signed off as competent 2.2.3 There is evidence of re-assessment and continuing competency

Section No: 3 Medication Administration Category: Critical / Major / Other / Satisfactory No Acceptance Criteria Audit Result 3.1 Inclusion / Exclusion Patients must meet the inclusion criteria for administration of medicines under the PGD. Inclusion criteria Comments 3.1.1 From PGD records analysed during audit, no patients have received treatment where PGD inclusion criteria have not been met 3.1.2 If any patients have received treatment where the PGD criteria have not been met, then the reasons have been documented 3.1.3 The PGD Group has been contacted to raise awareness of need to review inclusion criteria Exclusion criteria 3.1.4 Patients are referred to medical practitioners if they are excluded from treatment under PGD. 3.1.5 Reasons for referral are documented along with reasons for exclusion 3.1.5 Where a patient declines the treatment, the reasons are noted in the patient case notes and referral to medical practitioner documented

Section No: 3 Medication Administration Category: Critical / Major / Other / Satisfactory No Acceptance Criteria Audit Result 3.2 Recording the following details are recorded on the Patient Record Sheet by practitioners when administering a medicine under the PGD 3.2.1 Name of the practitioner supplying / administering mediciation under PGD Comments 3.2.2 Signature of practitioner 3.2.3 Patients/ carers are informed of fact that administration of medicine is within PGD protocol and consent is documented 3.2.4 If patient does not consent to treatment under PGD, resons are documented 3.2.4 Patient information supplied 3.2.5 Medication, route and strength is on record 3.2.6 Confirmation of patient meeting inclusion criteria 3.2.7 Details of exclusion criteria 3.2.8 Any adverse events noted 3.2.9 Evidence of completion of Clinical Incident form following an adverse event 3.2.10 A copy of the patient record sheet is held by the PGD practitioner and a second copy is placed in the patient notes

Section No: 3 Medication Administration (cont d) Category: Critical / Major / Other / Satisfactory No Acceptance Criteria Audit Result 3.3 Recording the following details are recorded on the Stock Record Sheet by practitioners when administering / supplying a medicine under the PGD 3.3.1 Date of supply / administration Comments 3.3.2 Patient Name 3.3.3 CHI number 3.3.4 Name of product 3.3.5 Product form 3.3.6 Product strength 3.3.7 Route of administration 3.3.8 Quantity supplied / administered 3.3.9 Batch No 3.3.10 Expiry date of product 3.3.11 Treatment period 3.3.12 Name of practitioner supplying / administering the medicine 3.3.13 Signature of practitioner supplying / administering the medicine

Section No: 4 Risk Management Category: Critical / Major / Other / Satisfactory No Acceptance Criteria Audit Result 4.1 Incident Reporting 4.1.1 There is an approved system (or systems) in place for reporting incidents and near misses involving the medicines administered under PGDs Comments 4.1.2 Incidents and near misses are recorded 4.1.3 Incidents and near misses are collated and sent to a central co-ordinator e.g. Datix or Safecode 4.1.4 Results of investigations and actions taken are formally recorded 4.1.5 Remedial actions are reviewed to ensure effectiveness 4.1.6 Any known suspected unexpected adverse drug reactions involving the medicine administered under a PGD are recorded via local policy / guidance on the patient record sheet 4.1.7 Any suspected unexpected adverse drug reactions involving the medicine administered under a PGD are recorded via national yellow card system and also on the patient record sheet 4.1.8 Reports for suspected unexpected drug reactions are available for review

Section No: 5 Storage Category: Critical / Major / Other / Satisfactory No Acceptance Criteria Audit Result 5.1 Storage of PGD medicines 5.1.1 Medicines for administration under PGDs are stored according to Safe and Secure Handling of Medicines policy Comments 5.1.2 Medicines are locked in appropriate drug cupboards (if applicable) 5.1.3 Medicines to be stored between 2 degrees C and 8 degrees C are stored in pharmaceutical refrigerators 5.1.4 Domestic refrigerators are not used 5.1.5 Temperatures are monitored in refrigerators using appropriately calibrated thermometers 5.1.6 Readings are recorded 5.1.7 Any results found to be out of specification are actioned 5.1.8 Pharmacy is contacted to assess the suitability of medicines for use following storage under incorrect conditions 5.1.9 An entry is made on the PGD stock record sheet for each supply / administration 5.1.10 There is evidence of correct stock rotation 5.1.11 Stock is correctly reconciled after each supply / administration

Section No: 6 Documentation Category: Critical / Major / Other / Satisfactory No Acceptance Criteria Audit Result Comments 6.1 General 6.1.1 All PGD documentation is subject to central document control 6.1.2 All PGD documentation is signed and dated before use 6.1.3 All PGD documentation is completed and signatures obtained prior to supply / administration of medicines 6.2 Archiving 6.2.1 All record sheets are retained in agreement with local and national policies for retention of documentation 6.2.2 A tested system is in place to allow retrieval of archived documentation if required

Section No: 7 Auditing PGD practice Category: Critical / Major / Other / Satisfactory No Acceptance Criteria Audit Result 7.1 Self-Inspection Comments 7.1.1 There is an approved procedure for carrying out regular self inspections/audits which includes how to follow up on actions reported during an inspection 7.1.2 The self-inspection schedule covers all aspects of the service 7.1.3 There is documented evidence that self-inspections are carried out 6 months after introduction of PGD and prior to each review (PGDs should be reviewed every 2 years) 7.1.4 There is evidence that corrective actions are dealt with appropriately and timeously 7.1.4 There is evidence that findings from audit have been communicated to all relevant members of staff